MediciNova, Inc. (MNOV)Healthcare | Biotechnology | La Jolla, United States | NasdaqGM
1.36 USD
-0.03
(-2.158%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 6:07 a.m. EDT
MediciNova presents a stark dichotomy between aggressive analyst optimism and crushing historical reality. While analysts project a mean target of $9.00—implying a massive multiple expansion from current levels—the company's fundamentals tell a different story. The business is hemorrhaging cash with negative operating margins and a trailing P/E that is mathematically undefined due to losses. More critically, the price history reveals a brutal structural decline; the stock has lost over 82% of its value over the last nine years, with the most recent annual performance showing another significant drop. This multi-year trajectory suggests the market has already priced out the worst-case scenarios, leaving very little room for error if clinical trials fail. The lack of dividend support and the absence of meaningful options flow confirm that this is a speculative vehicle for high-risk capital, not a stable investment. The 'strong buy' recommendation appears to be a mathematical outlier based on unrealistic growth assumptions rather than a reflection of the company's deteriorating operational health. |
| Model | MAE |
|---|---|
| MSTL_57 ✓ | 0.026081 |
| MSTL_50 | 0.032627 |
| AutoTheta | 0.034168 |
| MSTL_50_57 | 0.041306 |
| AutoETS | 0.042038 |
| AutoARIMA | 0.043518 |
| MSTL | 0.044961 |
Forecast horizon: 60 days | Selected: MSTL_57
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 1.16 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.276 |
| Excess Kurtosis | -0.90 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.419 |
| Revenue per Share | 0.012 |
| Market Cap | 66,940,896 |
| Forward P/E | -3.16 |
| Beta | 0.62 |
| Website | https://medicinova.com |
As of July 11, 2026, 6:07 a.m. EDT: Options activity is virtually dormant with negligible open interest and volume across all expirations. Implied volatility is extremely low, indicating a lack of speculative positioning or hedging demand. The sparse data suggests the market views this as a non-event asset with no defined near-term catalyst driving option flows.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.105691075 |
| Address1 | 4,275 Executive Square |
| Address2 | Suite 300 |
| All Time High | 16.12 |
| All Time Low | 1.12 |
| Ask | 1.74 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 69,310 |
| Average Daily Volume3 Month | 40,934 |
| Average Volume | 40,934 |
| Average Volume10Days | 69,310 |
| Beta | 0.619 |
| Bid | 0.9864 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 0.801 |
| City | La Jolla |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.36 |
| Current Ratio | 9.092 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.39 |
| Day Low | 1.36 |
| Debt To Equity | 0.419 |
| Display Name | MediciNova |
| Earnings Timestamp End | 1,786,651,200 |
| Earnings Timestamp Start | 1,786,651,200 |
| Ebitda | -12,897,116 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.084 |
| Enterprise To Revenue | 66.668 |
| Enterprise Value | 39,776,676 |
| Eps Current Year | -0.26 |
| Eps Forward | -0.43 |
| Eps Trailing Twelve Months | -0.23 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 858 404 0048 |
| Fifty Day Average | 1.3584 |
| Fifty Day Average Change | 0.0016000271 |
| Fifty Day Average Change Percent | 0.0011778763 |
| Fifty Two Week Change Percent | 10.569107 |
| Fifty Two Week High | 1.96 |
| Fifty Two Week High Change | -0.6 |
| Fifty Two Week High Change Percent | -0.30612245 |
| Fifty Two Week Low | 1.17 |
| Fifty Two Week Low Change | 0.19000006 |
| Fifty Two Week Low Change Percent | 0.16239321 |
| Fifty Two Week Range | 1.17 - 1.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,165,588,200,000 |
| Float Shares | 42,255,947 |
| Forward Eps | -0.43 |
| Forward P E | -3.1627908 |
| Free Cashflow | -5,838,312 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 6 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.080340005 |
| Gross Profits | 47,934 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02875 |
| Held Percent Institutions | 0.11038 |
| Implied Shares Outstanding | 49,221,246 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California. |
| Long Name | MediciNova, Inc. |
| Market | us_market |
| Market Cap | 66,940,896 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_9262264 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -11,720,095 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 67,187,000 |
| Number Of Analyst Opinions | 3 |
| Open | 1.41 |
| Operating Cashflow | -9,496,613 |
| Operating Margins | -15.16604 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 858 373 1500 |
| Previous Close | 1.39 |
| Price Eps Current Year | -5.2307696 |
| Price Hint | 4 |
| Price To Book | 1.6978776 |
| Price To Sales Trailing12 Months | 112.19627 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.907 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | -0.03 |
| Regular Market Change Percent | -2.15827 |
| Regular Market Day High | 1.39 |
| Regular Market Day Low | 1.36 |
| Regular Market Day Range | 1.36 - 1.39 |
| Regular Market Open | 1.41 |
| Regular Market Previous Close | 1.39 |
| Regular Market Price | 1.36 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 14,702 |
| Return On Assets | -0.16971001 |
| Return On Equity | -0.26238 |
| Revenue Per Share | 0.012 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 49,221,246 |
| Shares Percent Shares Out | 0.0042 |
| Shares Short | 204,812 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 172,764 |
| Short Name | MediciNova, Inc. |
| Short Percent Of Float | 0.0043 |
| Short Ratio | 3.82 |
| Source Interval | 15 |
| State | CA |
| Symbol | MNOV |
| Target High Price | 11.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 9.0 |
| Target Median Price | 10.0 |
| Total Cash | 27,329,416 |
| Total Cash Per Share | 0.555 |
| Total Debt | 165,198 |
| Total Revenue | 596,641 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.23 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.41615 |
| Two Hundred Day Average Change | -0.05614996 |
| Two Hundred Day Average Change Percent | -0.039649725 |
| Type Disp | Equity |
| Volume | 14,702 |
| Website | https://medicinova.com |
| Zip | 92,037 |